Answers are grounded in this paper and cite their sources.
Background:We frequently observe thyroid lesions in our day-to-day clinical work.In order to lessen the number of needless biopsies, auxiliary instruments for assessing thyroid lesions worthy of cytological evaluation should be developed.However, there are a number of limitations to ultrasound, such as equipment resolution differences, observer variability, and overlapping findings.TIRADS categorization makes an effort to reduce these drawbacks.Aims/ objective: To compare the clinical value of TIRADS in evaluating the malignancy of thyroid nodule with the final histopathological results in our setup. Materials and Method:A total of 93 patients with thyroid swelling with TIRADS category 2-5 were evaluated.Every patient had high resolution B-mode ultrasound.If thyroid nodules were found, they were classified using the ACR-TIRADS.The final histopathology results were reviewed and interpreted with the ultrasonography TIRADS categorization results.Results: Most of patients belonged to TIRADS 2 category (56.99%) followed by TIRADS 4 (22.58%) and TIRADS 3 (22.58%).Only 3.23% of patients belonged to TIRADS 5. Most of the patients (>80%) in TIRADS category 2 & 3 category had benign lesion.More than 60% patients in TIRADS 4 category had malignant lesion.TIRADS 5 category had 100% malignancy.TIRADS classification had more specificity (88.89%) and negative predictive value as compared to sensitivity (76.19%) and positive predictive value.Adenomatoid nodule was most common benign lesion whereas papillary carcinoma was most common malignant lesion. Conclusion:ACR-TIRADS classification is a very specific and accurate method for classifying benign and malignant nodules and a reliable signal for predicting cancer.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: